MDR – Article 65 – Clinical investigations on minors

Article 65

Clinical investigations on minors

A clinical investigation on minors may be conducted only where, in addition to the conditions set out in Article 62(4), all of the following conditions are met:

(a)the informed consent of their legally designated representative has been obtained;
(b)the minors have received the information referred to in Article 63(2) in a way adapted to their age and mental maturity and from
investigators or members of the investigating team who are trainedor experienced in working with children;
(c)the explicit wish of a minor who is capable of forming an opinion
and assessing the information referred to in Article 63(2) to refuse
participation in, or to withdraw from, the clinical investigation at
any time, is respected by the investigator;
(d)no incentives or financial inducements are given to the subject or
his or her legally designated representative except for compensation for expenses and loss of earnings directly related to the
participation in the clinical investigation;
(e)the clinical investigation is intended to investigate treatments for a medical condition that only occurs in minors or the clinical
investigation is essential with respect to minors to validate data
obtained in clinical investigations on persons able to give informed
consent or by other research methods;
(f)the clinical investigation either relates directly to a medical
condition from which the minor concerned suffers or is of such a
nature that it can only be carried out on minors;
(g)there are scientific grounds for expecting that participation in the
clinical investigation will produce a direct benefit to the minor
subject outweighing the risks and burdens involved;
(h)the minor shall take part in the informed consent procedure in a
way adapted to his or her age and mental maturity;
(i)if during a clinical investigation the minor reaches the age of legal
competence to give informed consent as defined in national law,
his or her express informed consent shall be obtained before that
subject can continue to participate in the clinical investigation.